Cargando…

Opinion of Polish Patients with Epilepsy on Generic Medications

Aim: The majority of medicines used in Poland are generic drugs and substitutions of the originals. The objective of this study was to obtain information on the current knowledge about generic medicines among Polish patients with epilepsy. Material and Methods: The conducted study was based on a sel...

Descripción completa

Detalles Bibliográficos
Autores principales: Swakowska, Katarzyna, Religioni, Urszula, Staniszewska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606757/
https://www.ncbi.nlm.nih.gov/pubmed/37893791
http://dx.doi.org/10.3390/healthcare11202717
_version_ 1785127392440745984
author Swakowska, Katarzyna
Religioni, Urszula
Staniszewska, Anna
author_facet Swakowska, Katarzyna
Religioni, Urszula
Staniszewska, Anna
author_sort Swakowska, Katarzyna
collection PubMed
description Aim: The majority of medicines used in Poland are generic drugs and substitutions of the originals. The objective of this study was to obtain information on the current knowledge about generic medicines among Polish patients with epilepsy. Material and Methods: The conducted study was based on a self-developed questionnaire. The questionnaire consisted of 26 questions, including the questions regarding the respondents’ knowledge about generics, their previous experience, and the factors behind these choices. Results: Overall, 1220 questionnaires were analyzed. Among all patients, 66.4% reportedly had heard about generics. Of these, 61.5% of patients had used generic drugs in the past. A significant proportion of participants had never been recommended to switch to a generic medicine by their healthcare professional (23% physicians and 13.9% pharmacists). Statistically, relevant differences were observed regarding the respondents’ kind and level of education, place of residence, and net income per household. Conclusions: Significant gaps were identified in the knowledge and perceptions among patients regarding generic medicines, especially in relation to their efficacy and safety. Efforts must be directed towards increasing public awareness of generic medicines and there should also be a focus on educating patients about generic medicines.
format Online
Article
Text
id pubmed-10606757
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106067572023-10-28 Opinion of Polish Patients with Epilepsy on Generic Medications Swakowska, Katarzyna Religioni, Urszula Staniszewska, Anna Healthcare (Basel) Article Aim: The majority of medicines used in Poland are generic drugs and substitutions of the originals. The objective of this study was to obtain information on the current knowledge about generic medicines among Polish patients with epilepsy. Material and Methods: The conducted study was based on a self-developed questionnaire. The questionnaire consisted of 26 questions, including the questions regarding the respondents’ knowledge about generics, their previous experience, and the factors behind these choices. Results: Overall, 1220 questionnaires were analyzed. Among all patients, 66.4% reportedly had heard about generics. Of these, 61.5% of patients had used generic drugs in the past. A significant proportion of participants had never been recommended to switch to a generic medicine by their healthcare professional (23% physicians and 13.9% pharmacists). Statistically, relevant differences were observed regarding the respondents’ kind and level of education, place of residence, and net income per household. Conclusions: Significant gaps were identified in the knowledge and perceptions among patients regarding generic medicines, especially in relation to their efficacy and safety. Efforts must be directed towards increasing public awareness of generic medicines and there should also be a focus on educating patients about generic medicines. MDPI 2023-10-12 /pmc/articles/PMC10606757/ /pubmed/37893791 http://dx.doi.org/10.3390/healthcare11202717 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Swakowska, Katarzyna
Religioni, Urszula
Staniszewska, Anna
Opinion of Polish Patients with Epilepsy on Generic Medications
title Opinion of Polish Patients with Epilepsy on Generic Medications
title_full Opinion of Polish Patients with Epilepsy on Generic Medications
title_fullStr Opinion of Polish Patients with Epilepsy on Generic Medications
title_full_unstemmed Opinion of Polish Patients with Epilepsy on Generic Medications
title_short Opinion of Polish Patients with Epilepsy on Generic Medications
title_sort opinion of polish patients with epilepsy on generic medications
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606757/
https://www.ncbi.nlm.nih.gov/pubmed/37893791
http://dx.doi.org/10.3390/healthcare11202717
work_keys_str_mv AT swakowskakatarzyna opinionofpolishpatientswithepilepsyongenericmedications
AT religioniurszula opinionofpolishpatientswithepilepsyongenericmedications
AT staniszewskaanna opinionofpolishpatientswithepilepsyongenericmedications